Piper Sandler lowers Arbor Realty Trust stock price target on credit issues
Earlyworks Co., Ltd. (NASDAQ:ELWS) announced Thursday that it has called an extraordinary general meeting of shareholders to be held in Tokyo, Japan on November 14, 2025. The company has sent notices and proxy materials to all holders of its ordinary shares and American Depositary Shares, according to a statement based on a press release filed with the U.S. Securities and Exchange Commission. The company, which reported revenue of $4.83 million in the last twelve months as of Q2 2025, currently maintains a "FAIR" financial health rating according to InvestingPro data.
The agenda for the meeting includes proposals to authorize potential share issuances. The company clarified that these proposals do not seek shareholder approval for the acquisition of PrimeDelta Corp., but rather would authorize share issuances that may be used in connection with a possible future acquisition of PrimeDelta Corp. Any such transaction would be subject to the completion of due diligence and the execution of a definitive agreement. With a current ratio of 3.05 and minimal debt of $0.95, Earlyworks appears positioned with financial flexibility despite posting negative EBITDA of $7.55 million in the last twelve months.
The meeting notice and proxy card have been furnished as exhibits to the SEC filing. Earlyworks stated that the agenda items are designed to provide flexibility for potential future corporate actions but do not constitute approval for any specific acquisition at this time. The company’s revenue declined by 11.94% year-over-year, with a relatively low beta of 0.55, indicating less volatility than the broader market. InvestingPro offers additional insights with exclusive financial metrics and ProTips to help investors evaluate potential impacts of Earlyworks’ strategic moves.
In other recent news, Erayak Power Solution Group Inc. has entered into an at-the-market sales agreement with Craft Capital Management LLC, allowing the company to offer and sell up to $10 million of its Class A ordinary shares. This agreement enables Erayak to conduct sales directly on exchanges or through market makers. Meanwhile, AstraZeneca PLC has announced plans to harmonize its share listing across major exchanges, replacing its current US American Depositary Receipts on Nasdaq with a direct listing on the New York Stock Exchange. This strategic move aims to facilitate shareholder trading across the London Stock Exchange, Nasdaq Stockholm, and the NYSE.
Novo Nordisk A/S has called an Extraordinary General Meeting for November 14, 2025, to elect new board members, with several current members not standing for re-election. REE Automotive Ltd. has scheduled a special general meeting of shareholders on November 13, 2025, providing a proxy statement and form of proxy card for voting procedures. Additionally, Enlivex Therapeutics Ltd. will hold its Annual General Meeting of Shareholders on November 10, 2025, with further details available in their latest SEC filing. These developments highlight significant corporate activities and governance changes across these companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.